Anzeige
Mehr »
Login
Mittwoch, 26.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
Die DeepSeek-Revolution: Pioneer AIs Multi-Agent-Strategie lässt die Konkurrenz alt aussehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU8Q | ISIN: CA74141E1043 | Ticker-Symbol: 18H
Frankfurt
26.02.25
08:00 Uhr
0,013 Euro
-0,001
-3,85 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PREVECEUTICAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
PREVECEUTICAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0150,02118:02

Aktuelle News zur PREVECEUTICAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln
06.02.PreveCeutical Medical Inc.: PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease196Vancouver, British Columbia--(Newsfile Corp. - February 6, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces a program aiming to...
► Artikel lesen
04.02.Preveceutical Medical Inc: Preveceutical appoints Jones to lead Sol-Gel projects3
04.02.PreveCeutical Medical Inc.: Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects162Vancouver, British Columbia--(Newsfile Corp. - February 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), (the "Company" or "PreveCeutical") a health sciences company that...
► Artikel lesen
24.01.PreveCeutical Medical Inc.: PreveCeutical Announces Non-Brokered Private Placement767Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered...
► Artikel lesen
07.01.PreveCeutical Medical Inc.: BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference463Vancouver, British Columbia--(Newsfile Corp. - January 7, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
18.12.24PreveCeutical Medical Inc.: PreveCeutical Announces Change of Auditors397Vancouver, British Columbia--(Newsfile Corp. - December 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that the Company has...
► Artikel lesen
09.12.24Preveceutical Medical Inc: Preveceutical's BioGene appoints Lawson as director6
09.12.24PreveCeutical Medical Inc.: BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors397Vancouver, British Columbia--(Newsfile Corp. - December 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
05.12.24Preveceutical Medical Inc: Preveceutical's BioGene adds Ticho to advisory board5
05.12.24PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho825Vancouver, British Columbia--(Newsfile Corp. - December 5, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
04.12.24Preveceutical Medical Inc: Preveceutical's BioGene appoints advisory board member3
04.12.24PreveCeutical Medical Inc.: BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board247Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
02.12.24Preveceutical Medical Inc: Preveceutical unit appoints Glover independent director2
02.12.24PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Stephen Glover to Its Board of Directors222Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
25.11.24Preveceutical Medical Inc: Preveceutical's BioGene appoints Sampath as director1
25.11.24PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors246Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
21.11.24Preveceutical Medical Inc: Preveceutical's BioGene adds Dellbegovic as adviser2
21.11.24PreveCeutical Medical Inc.: BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board295Vancouver, British Columbia--(Newsfile Corp. - November 21, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
18.11.24Preveceutical Medical Inc: Preveceutical names Olofsson chief scientific officer2
18.11.24PreveCeutical Medical Inc.: PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer172Vancouver, British Columbia--(Newsfile Corp. - November 18, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that...
► Artikel lesen
Seite:  Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1